HOLLY LEANN THOMAS
- Type
- Non-physician practitioner · Physician Assistants & Advanced Practice Nursing Providers / Nurse Practitioner / Psychiatric/Mental Health
- Where
- MONTGOMERY CITY, MO
- NPI
- 1447087432
- Received
- $909 in 48 records, 2024 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 45 | $852 |
| 2024 | General payment | 3 | $57 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $208 | 2025 |
| Neurocrine BioSciences, Inc. | 11 | $177 | 2024–2025 |
| Alkermes, Inc. | 10 | $167 | 2025 |
| Vanda Pharmaceuticals Inc. | 6 | $129 | 2025 |
| Otsuka America Pharmaceutical, Inc. | 6 | $108 | 2024–2025 |
| ABBVIE INC. | 2 | $29 | 2024–2025 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 | 2025 |
| Axsome Therapeutics, Inc. | 1 | $18 | 2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 | 2025 |
| Janssen Pharmaceuticals, Inc | 1 | $14 | 2025 |
| E.R. Squibb & Sons, L.L.C. | 1 | $13 | 2025 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 47 | $797 |
| Education | 1 | $111 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-17 | Alkermes, Inc. | $19 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-12-11 | Teva Pharmaceuticals USA, Inc. | $8 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-12-10 | Vanda Pharmaceuticals Inc. | $23 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-12-03 | Neurocrine BioSciences, Inc. | $22 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-11-24 | Vanda Pharmaceuticals Inc. | $16 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-11-20 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-13 | Teva Pharmaceuticals USA, Inc. | $16 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-11-12 | Otsuka America Pharmaceutical, Inc. | $22 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-11-06 | Neurocrine BioSciences, Inc. | $18 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-11-05 | Alkermes, Inc. | $13 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-10-30 | Vanda Pharmaceuticals Inc. | $29 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-10-29 | E.R. Squibb & Sons, L.L.C. | $13 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-18 | Alkermes, Inc. | $22 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-10-15 | Teva Pharmaceuticals USA, Inc. | $17 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-09-03 | Neurocrine BioSciences, Inc. | $24 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-03 | Neurocrine BioSciences, Inc. | $1 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-25 | Vanda Pharmaceuticals Inc. | $27 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-21 | Axsome Therapeutics, Inc. | $18 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-18 | Takeda Pharmaceuticals U.S.A., Inc. | $23 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-08-15 | Neurocrine BioSciences, Inc. | $16 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-15 | Teva Pharmaceuticals USA, Inc. | $13 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-08-14 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2025 | |
| 2025-08-11 | Neurocrine BioSciences, Inc. | $25 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-11 | Neurocrine BioSciences, Inc. | $4 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-09 | Teva Pharmaceuticals USA, Inc. | $14 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-08 | Vanda Pharmaceuticals Inc. | $15 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-07-08 | Otsuka America Pharmaceutical, Inc. | $15 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2025-06-10 | Vanda Pharmaceuticals Inc. | $17 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-05-14 | Teva Pharmaceuticals USA, Inc. | $12 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-05-07 | Janssen Pharmaceuticals, Inc | $14 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-04-23 | Alkermes, Inc. | $7 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-04-23 | Alkermes, Inc. | $2 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-04-17 | Teva Pharmaceuticals USA, Inc. | $111 | Education | In-kind items and services | 2025 | ||
| 2025-04-01 | Alkermes, Inc. | $80 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-04-01 | Otsuka America Pharmaceutical, Inc. | $16 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2025-03-24 | Teva Pharmaceuticals USA, Inc. | $14 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-03-13 | Neurocrine BioSciences, Inc. | $21 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-12 | Neurocrine BioSciences, Inc. | $0 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-04 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-18 | Alkermes, Inc. | $13 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-02-04 | Otsuka America Pharmaceutical, Inc. | $15 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2025-01-28 | Alkermes, Inc. | $7 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-01-28 | Alkermes, Inc. | $0 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-01-28 | Alkermes, Inc. | $0 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-01-10 | Neurocrine BioSciences, Inc. | $16 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2024-12-16 | Neurocrine BioSciences, Inc. | $23 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-12-10 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-11-12 | Otsuka America Pharmaceutical, Inc. | $19 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2024 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Montgomery City, MO, county Montgomery County, MO, state Missouri; placed by its city name.
| Measure | Place (city or town) Montgomery City, MO | County Montgomery County, MO | State Missouri |
|---|---|---|---|
| Population B01003 | 2,801 | 11,426 | 6,191,814 |
| Population, 2020 census P1 | 2,811 | 11,322 | 6,154,913 |
| Median age B01002 | 33.8 | 43.6 | 39.0 |
| Under 18 B01001 | 24.6% | 21.9% | 22.3% |
| 65 and over B01001 | 14.0% | 20.5% | 17.9% |
| Households B11001 | 1,184 | 4,640 | 2,508,227 |
| Foreign born B05002 | 1.4% | 0.9% | 4.5% |
| Median household income B19013 | $57,500 | $65,500 | $70,702 |
| Median family income B19113 | $70,223 | $75,122 | $91,360 |
| Per capita income B19301 | $27,232 | $30,947 | $39,695 |
| Poverty rate B17001 | 17.7% | 13.9% | 12.6% |
| Unemployment rate B23025 | 3.9% | 3.0% | 4.0% |
| Civilian labor force B23025 | 1,446 | 5,289 | 3,120,639 |
| Mean commute (minutes) B08013 | 26.1 | 28.7 | 23.5 |
| Bachelor's degree or higher B15003 | 20.2% | 17.7% | 32.4% |
| Housing units B25001 | 1,313 | 5,832 | 2,825,287 |
| Owner-occupied B25003 | 65.6% | 73.4% | 68.1% |
| Renters B25003 | 34.4% | 26.6% | 31.9% |
| Median home value B25077 | $161,100 | $178,700 | $230,300 |
| Median gross rent B25064 | $767 | $788 | $1,033 |
| White, not Hispanic B03002 | 87.2% | 92.3% | 76.3% |
| Black B03002 | 2.5% | 0.8% | 10.9% |
| Hispanic or Latino B03002 | 3.6% | 2.3% | 5.2% |
| Asian B03002 | 0.3% | 0.1% | 2.1% |
| American Indian and Alaska Native B03002 | 0.9% | 0.3% | 0.2% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Montgomery City, MO.
Comments